China Pharma Holdings (CPHI) Long-Term Deferred Tax (2011 - 2026)
China Pharma Holdings' (CPHI) quarterly Long-Term Deferred Tax came in at $21.8 million in Q1 2026, down 0.54% YoY from $21.9 million in Q1 2025, and up 2.83% on a QoQ basis from $21.2 million in Q4 2025.
China Pharma Holdings (CPHI) Long-Term Deferred Tax (2011 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 15 years of Long-Term Deferred Tax data on file, last reported at $21.8 million in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 0.54% year-over-year to $21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.8 million (down 0.54% YoY) and the FY2025 annual result came in at $21.2 million, down 2.3% from the prior year.
- Long-Term Deferred Tax rose to $21.8 million in Q1 2026, from $21.2 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $23.8 million in Q1 2022 to a low of $20.0 million in Q2 2023.
- A 5-year average of $21.8 million and a median of $21.8 million in 2026 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax sank 43.81% — and 2023, when it increased 7.12%.
- Tracing CPHI's Long-Term Deferred Tax over 5 years: stood at $20.1 million in 2022, then rose by 7.12% to $21.5 million in 2023, then grew by 0.78% to $21.7 million in 2024, then slipped by 2.3% to $21.2 million in 2025, then grew by 2.83% to $21.8 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $21.8 million (Q1 2026), $21.2 million (Q4 2025), and $22.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | China Pharma Holdings | 42.55 Mn | 42.24 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.80 Mn |
| Dec 31, 2025 | 21.20 Mn |
| Sep 30, 2025 | 22.70 Mn |
| Jun 30, 2025 | 22.10 Mn |
| Mar 31, 2025 | 21.92 Mn |
| Dec 31, 2024 | 21.70 Mn |
| Dec 31, 2023 | 21.53 Mn |
| Jun 30, 2023 | 20.00 Mn |
| Mar 31, 2023 | 20.60 Mn |
| Dec 31, 2022 | 20.10 Mn |
| Sep 30, 2022 | 22.70 Mn |
| Jun 30, 2022 | 23.20 Mn |
| Mar 31, 2022 | 23.80 Mn |
| Dec 31, 2021 | 23.98 Mn |
| Sep 30, 2021 | 40.40 Mn |
| Jun 30, 2021 | 39.80 Mn |
| Mar 31, 2021 | 38.40 Mn |
| Dec 31, 2020 | 27.67 Mn |
| Sep 30, 2020 | 51.70 Mn |
| Jun 30, 2020 | 51.70 Mn |